Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study

BACKGROUND: The management of breakthrough pain (BTP) in cancer patients is a challenge. It is clinically useful to evaluate the effectiveness of rapid-onset opioid at a starting dose in proportional to the background opioid regimen. This open-label, multicenter, noncomparative study aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Tsung-Yu, Chiou, Jeng-Fong, Chiang, Wei-Yong, Su, Wen-Hao, Huang, Ming-Yuan, Hu, Ming-Hung, Wu, Shen-Chi, Lai, Yuen-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078661/
https://www.ncbi.nlm.nih.gov/pubmed/30045291
http://dx.doi.org/10.1097/MD.0000000000011593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078661/
https://www.ncbi.nlm.nih.gov/pubmed/30045291
http://dx.doi.org/10.1097/MD.0000000000011593

Ejemplares similares